Literature DB >> 3800074

Serum digoxin levels and mortality in 5,100 patients.

G J Ordog, S Benaron, V Bhasin, J Wasserberger, S Balasubramanium.   

Abstract

A retrospective study of 5,100 patients on digoxin, with a four-week follow up after digoxin levels were measured, was done to determine the mortality rate. A significant increase in mortality was correlated with an increasing serum digoxin level, up to 50% at a level of 6.0 ng/mL and more. Clinical toxicity was suspected in only 0.25% of all patients on digoxin, although almost 10% had levels above the therapeutic range. Deliberate digoxin overdoses were fatal in 50% of cases. This study shows a correlation between increasing digoxin levels and increasing mortality rates. We recommend the use of serum digoxin measurements to identify those asymptomatic patients with elevated levels. The physician should seriously consider the indications for initiating or continuing digoxin treatment in any patient because of an increased mortality in patients with levels of more than 1.0 ng/mL.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3800074     DOI: 10.1016/s0196-0644(87)80281-0

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  10 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic drugs.

Authors:  Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Digoxin or angiotensin converting enzyme inhibitors for congestive heart failure in geriatric patients. Which is the preferred treatment?

Authors:  W S Aronow
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

3.  Prognostic utility of serum potassium in chronic digoxin toxicity: a case-control study.

Authors:  Alex F Manini; Lewis S Nelson; Robert S Hoffman
Journal:  Am J Cardiovasc Drugs       Date:  2011-06-01       Impact factor: 3.571

Review 4.  Advances in the management of digoxin toxicity in the older patient.

Authors:  S W Borron; C Bismuth; J Muszynski
Journal:  Drugs Aging       Date:  1997-01       Impact factor: 3.923

Review 5.  Age-related differences in digoxin toxicity and its treatment.

Authors:  T G Wells; R A Young; G L Kearns
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

6.  Assessment of digoxin antibody use in patients with elevated serum digoxin following chronic or acute exposure.

Authors:  Frédéric Lapostolle; Stephen W Borron; Carine Verdier; Fabrice Arnaud; James Couvreur; Bruno Mégarbane; Frédéric Baud; Frédéric Adnet
Journal:  Intensive Care Med       Date:  2008-04-04       Impact factor: 17.440

Review 7.  Digoxin toxicity in the aged. Characterising and avoiding the problem.

Authors:  A P Passmore; G D Johnston
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

8.  Digoxin--'a friend or foe'.

Authors:  Kolyu Kirov Kolev
Journal:  BMJ Case Rep       Date:  2012-09-24

9.  Retrospective evaluation of patients with elevated digoxin levels at an emergency department.

Authors:  Gulsum Limon; Gurkan Ersoy; Nese Colak Oray; Basak Bayram; Onder Limon
Journal:  Turk J Emerg Med       Date:  2016-03-14

10.  Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data.

Authors:  Toshinori Hirai; Hidefumi Kasai; Miyoko Naganuma; Nobuhisa Hagiwara; Tsuyoshi Shiga
Journal:  BMC Pharmacol Toxicol       Date:  2022-02-10       Impact factor: 2.483

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.